glp-1 agonist drugs oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Oral GLP-1: A Needle-Free Solution

Additionally, Arg at the 34th position is replaced with Lys to accommodate site-specific acylation

doi: 10.1136/jim-2017-000445 48 WilliamsDMNawazAEvansM

Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study

According to research, modifying the gut microbiota can impact various physiological functions, including cognitive behavior and muscle performance [112]

Diabetes Obes Metab 24(8):15531564 Wharton S et al (2021) Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data

The receptor was pivotal to the ability to create long-lasting GLP-1 drugs for diabetes and obesity